Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Central Nervous System Neoplasms 7Lymphoma 6Glioblastoma 6Gliosarcoma 5Hodgkin Disease 4Astrocytoma 4Burkitt Lymphoma 3Recurrence 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Glioma 2Waldenstrom Macroglobulinemia 1Plasmablastic Lymphoma 1Neutropenia 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Polymerase Chain Reaction 5Watchful Waiting 2Taxes 2Paclitaxel 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2nirogacestat 1fludarabine 1emvododstat 1carmustine, poliferprosan 20 drug combination 1axicabtagene ciloleucel 1Vorinostat 1Vincristine 1Vinblastine 1Sodium Chloride 1Smoking Devices 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Procarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × HIV Infections × Carmustine × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡